Biochemical Engineering

News

Business and IChemE news related to Biochemical Engineering including biopharm, Cell & gene therapy and industrial biotech.

1st November 2024

UCB's tau drug flunks phase 2 Alzheimer's trial

The week after seeing its partner Roche cut and run, UCB has reported the failure of its anti-tau antibody bepranemab to improve cognition and function in people with early Alzheimer’s disease. But...

29th October 2024

GSK aims to extend lupus dominance via $300M upfront deal for clinical-stage T-cell engager

GSK is handing over $300 million in upfront cash for a clinical-stage T-cell engager it believes could target patients who aren’t benefiting from current treatments. The candidate in question is CM...

24th October 2024

Bicycle switches on to radiopharma in new cancer breakthrough

Based in Cambridge and the US and quoted on Nasdaq in the States, Bicycle has presented the first human imaging data validating the potential of MT1-MMP as a novel target in the treatment of cancer...

15th October 2024

MeiraGTx's gene therapy improves motor function and quality of life in phase 2 Parkinson's trial

MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ability and quality of life in a small midphase trial. A total of 14 patien...

14th October 2024

Lilly picks UK for first European Gateway Lab as part of $364M investment plan

The UK’s world-leading life sciences sector will receive a £279 million boost with an intent expressed by Lilly to invest in the UK as part of a collaborative partnership with UK government, announ...

9th October 2024

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases

Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 million in a Series B financing. Purespri...

24th September 2024

Charles River, Ori Biotech Cell Therapy Manufacturing Platform Collaboration Yields Promising Results

Charles River Laboratories and Ori Biotech, a manufacturing technology company with hubs in London and Philadelphia, jointly announced some results of a collaboration that began earlier in 2024, wi...

24th September 2024

Quell partners with eXmoor for CARTreg therapy

Quell Therapeutics Ltd, a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, and eXmoor pharma, the full-service ce...

24th September 2024

Lonza to Manufacture Commercial Supply of Vertex’s Cell Therapy, CASGEVY

Lonza announced that it has entered into a long-term commercial supply agreement with Vertex Pharmaceuticals to manufacture Casgevy (exagamglogene autotemcel), the first clustered regularly intersp...

19th September 2024

Achilles drops cell therapy program, braces for layoffs

Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, looking into deals with groups working on other modalities and preparing to ...

19th September 2024

MiAlgae nets $18.5m to scale production of omega-3s from microalgae

MiAlgae—a startup growing microalgae in fermentation tanks to produce omega-3 fatty acids—has raised a £14 million series A round to fund a new commercial-scale facility in Scotland. The round was ...

11th September 2024

Innovative medicine production site inaugurated in France

Sanofi has inaugurated a new production unit in France which utilises a world-first modular concept. The site, Modulus, located in Neuville-sur-Saône (Rhône-Alpes), is supported by an investment of...